Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The combination therapy was effective and well-tolerated, especially in young patients.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib may help regrow hair in alopecia areata patients.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.